1. Home
  2. CRNX vs UE Comparison

CRNX vs UE Comparison

Compare CRNX & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • UE
  • Stock Information
  • Founded
  • CRNX 2008
  • UE 2014
  • Country
  • CRNX United States
  • UE United States
  • Employees
  • CRNX N/A
  • UE N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • UE Real Estate
  • Sector
  • CRNX Health Care
  • UE Finance
  • Exchange
  • CRNX Nasdaq
  • UE Nasdaq
  • Market Cap
  • CRNX 2.8B
  • UE 2.5B
  • IPO Year
  • CRNX 2018
  • UE N/A
  • Fundamental
  • Price
  • CRNX $33.77
  • UE $20.66
  • Analyst Decision
  • CRNX Strong Buy
  • UE Buy
  • Analyst Count
  • CRNX 7
  • UE 3
  • Target Price
  • CRNX $74.33
  • UE $22.67
  • AVG Volume (30 Days)
  • CRNX 1.1M
  • UE 1.0M
  • Earning Date
  • CRNX 11-11-2025
  • UE 10-29-2025
  • Dividend Yield
  • CRNX N/A
  • UE 3.66%
  • EPS Growth
  • CRNX N/A
  • UE N/A
  • EPS
  • CRNX N/A
  • UE 0.84
  • Revenue
  • CRNX $1,392,000.00
  • UE $461,043,000.00
  • Revenue This Year
  • CRNX $489.51
  • UE $6.41
  • Revenue Next Year
  • CRNX $661.93
  • UE $4.02
  • P/E Ratio
  • CRNX N/A
  • UE $24.62
  • Revenue Growth
  • CRNX 0.51
  • UE 8.59
  • 52 Week Low
  • CRNX $24.10
  • UE $15.66
  • 52 Week High
  • CRNX $62.53
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 56.44
  • UE 52.96
  • Support Level
  • CRNX $33.19
  • UE $20.32
  • Resistance Level
  • CRNX $37.23
  • UE $21.29
  • Average True Range (ATR)
  • CRNX 1.45
  • UE 0.38
  • MACD
  • CRNX 0.11
  • UE -0.03
  • Stochastic Oscillator
  • CRNX 52.12
  • UE 38.52

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: